Study finds 84% fewer hospitalizations for patients treated with controversial drug hydroxychloroquine
(Worthy News) – A peer-reviewed study measuring the effectiveness of a controversial drug cocktail that includes hydroxychloroquine concluded that the treatment lowered hospitalizations and mortality rates of coronavirus patients.
The study, set to be published in the International Journal of Antimicrobial Agents in December, determined that “Low-dose hydroxychloroquine combined with zinc and azithromycin was an effective therapeutic approach against COVID-19.”
A total of 141 patients diagnosed with the coronavirus were treated with the three-drug cocktail over a period of five days and compared to a control group of 377 people who tested positive for the virus but were not given the treatment.
The study found that “the odds of hospitalisation of treated patients was 84% less than in the untreated patients,” and only one patient died from the group being treated with the drugs compared to 13 deaths in the untreated group. [ Source: Washington Examiner (Read More…) ]
Worthy News reports from a biblical worldview with a commitment to accuracy, transparency, and editorial independence. Learn more about About Worthy News, our Editorial Standards, AI Use Policy, Ownership of Worthy News, News Tips and Corrections, and Worthy News Staff.
💡 Did you know? One of the best ways you can support Worthy News is by simply leaving a comment and sharing this article.
📢 Social media algorithms push content further when there’s more engagement — so every 👍 like, 💬 comment, and 🔄 share helps more people discover the truth. 🙌
Latest Worthy News
Books by George Whitten
The Eternal Kingdom Revealed https://eternalkingdomrevealed.com
The Eternal Kingdom Revealed traces the Kingdom of God as the central story of Scripture, from before creation to the restoration of all things.
Identity in Messiah Revealed https://identityinmessiah.com
A devotional journey calling believers out of self-doubt and into confident, Kingdom-rooted identity in the Messiah.
As an Amazon Associate I earn from qualifying purchases.
